From the *Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
†Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
‡Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
§Macha Research Trust, Choma, Zambia
¶Department of Paediatrics and Child Health, Livingstone Central Hospital, Livingstone, Zambia
∥Department of Immunology and Infectious Diseases, Erasmus University, Rotterdam, the Netherlands.
Accepted for publication January 15, 2023
The DBS, EID and PART studies were supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreements (U62/CCU322428 to WJM and 5U2GPS001930 to PET) from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The NSEBA study was supported by a grant from the National Institutes of Allergy and Infectious Disease (R01AI116324 to WJM). The findings and conclusions included in its content are solely the responsibility of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
The authors have no conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).
Address for correspondence: Catherine G. Sutcliffe, PhD, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Rm E6535, Baltimore, MD. E-mail: [email protected].
